TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 4 filers reported holding TANDEM DIABETES CARE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,928 | -42.6% | 815 | -32.1% | 0.00% | -33.3% |
| Q2 2023 | $29,473 | -31.6% | 1,201 | +13.2% | 0.00% | -25.0% |
| Q1 2023 | $43,088 | +14.0% | 1,061 | +26.2% | 0.00% | 0.0% |
| Q4 2022 | $37,803 | +45.4% | 841 | +53.5% | 0.00% | +33.3% |
| Q3 2022 | $26,000 | -16.1% | 548 | +6.0% | 0.00% | -25.0% |
| Q2 2022 | $31,000 | +82.4% | 517 | +244.7% | 0.00% | +100.0% |
| Q1 2022 | $17,000 | +6.2% | 150 | +38.9% | 0.00% | 0.0% |
| Q4 2021 | $16,000 | +33.3% | 108 | +4.9% | 0.00% | 0.0% |
| Q3 2021 | $12,000 | +20.0% | 103 | +5.1% | 0.00% | +100.0% |
| Q2 2021 | $10,000 | -23.1% | 98 | -33.8% | 0.00% | -50.0% |
| Q1 2021 | $13,000 | +8.3% | 148 | +20.3% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | -14.3% | 123 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $14,000 | +16.7% | 123 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $12,000 | +100.0% | 123 | +30.9% | 0.00% | +200.0% |
| Q1 2020 | $6,000 | -14.3% | 94 | -26.0% | 0.00% | 0.0% |
| Q4 2019 | $7,000 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |